Abstract: A neuroprotective mixture includes Phosphocreatine (PCr), Magnesium Gluconate (MgG), and ß-hydroxybutyrate (BHB). The PCR, MgG, and BHB are combined in a 2:1:2 molar ratio of PCr:MgH:BHB. The neuroprotective mixture is a useful preventative and prophylactic supplement, which also can function to extend the post-stroke treatment window.
Type:
Grant
Filed:
November 16, 2020
Date of Patent:
July 4, 2023
Assignee:
TRICERAPRO HOLDING, LLC
Inventors:
Joseph L. Clark, Todd J. Crocco, Charles L. Rosen, Steven Cutright
Abstract: A neuroprotective mixture includes Phosphocreatine (PCr), Magnesium Gluconate (MgG), and ?-hydroxybutyrate (BHB). The PCR, MgG, and BHB are combined in a 2:1:2 molar ratio of PCr:MgH:BHB. The neuroprotective mixture is a useful preventative and prophylactic supplement, which also can function to extend the post-stroke treatment window.
Type:
Grant
Filed:
March 15, 2019
Date of Patent:
December 15, 2020
Assignee:
TRICERAPRO HOLDING, LLC
Inventors:
Joseph L. Clark, Todd J. Crocco, Charles L. Rosen, Steven Cutright